Alteryx, Inc. (NYSE:AYX)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $76.62 and last traded at $76.62, with a volume of 2724 shares. The stock had previously closed at $79.11.
Several brokerages have recently issued reports on AYX. Needham & Company LLC decreased their price target on shares of Alteryx from $159.00 to $157.00 and set a “buy” rating for the company in a research note on Wednesday, February 10th. Truist initiated coverage on shares of Alteryx in a research report on Wednesday, January 20th. They set a “buy” rating and a $150.00 target price for the company. Cowen lowered their target price on shares of Alteryx from $155.00 to $150.00 and set an “outperform” rating on the stock in a report on Tuesday, January 5th. Loop Capital reduced their target price on Alteryx from $140.00 to $110.00 in a report on Tuesday, January 5th. Finally, Rosenblatt Securities reiterated a “buy” rating on shares of Alteryx in a research note on Tuesday, April 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $153.92.
The company has a quick ratio of 4.03, a current ratio of 4.03 and a debt-to-equity ratio of 1.49. The company has a market capitalization of $5.05 billion, a P/E ratio of -293.00, a price-to-earnings-growth ratio of 87.28 and a beta of 0.85. The company has a 50-day moving average of $84.25 and a two-hundred day moving average of $109.93.
In other news, Director Dean Stoecker sold 7,500 shares of the business’s stock in a transaction on Wednesday, February 3rd. The shares were sold at an average price of $128.57, for a total transaction of $964,275.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeff Horing sold 6,081 shares of the firm’s stock in a transaction on Thursday, February 25th. The stock was sold at an average price of $98.32, for a total value of $597,883.92. Following the completion of the transaction, the director now directly owns 1,375 shares in the company, valued at $135,190. The disclosure for this sale can be found here. Insiders have sold a total of 86,721 shares of company stock worth $8,992,427 in the last 90 days. Company insiders own 13.58% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of AYX. Whittier Trust Co. grew its stake in Alteryx by 5.8% during the fourth quarter. Whittier Trust Co. now owns 14,847 shares of the company’s stock valued at $1,808,000 after acquiring an additional 810 shares in the last quarter. Candriam Luxembourg S.C.A. increased its stake in Alteryx by 185.3% in the 4th quarter. Candriam Luxembourg S.C.A. now owns 8,045 shares of the company’s stock worth $975,000 after acquiring an additional 5,225 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Alteryx during the 4th quarter worth approximately $1,176,000. Truvestments Capital LLC bought a new stake in Alteryx in the fourth quarter worth $232,000. Finally, Koshinski Asset Management Inc. purchased a new stake in Alteryx during the fourth quarter valued at $628,000. 75.06% of the stock is currently owned by institutional investors.
Alteryx Company Profile (NYSE:AYX)
Alteryx, Inc provides end-to-end analytics platform for data analysts and scientists worldwide. Its analytic process automation software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.
Featured Story: The Structure of a Futures Contract
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.